Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 1644 for:    Slovakia

Intradialytic Resistance Training in Haemodialysis Patients (IRTHEP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03511924
Recruitment Status : Active, not recruiting
First Posted : April 30, 2018
Last Update Posted : August 26, 2019
Sponsor:
Collaborators:
Dialysis Services Fresenius Medical Care Slovakia
Private Health Institution Logman - Logman East
Information provided by (Responsible Party):
Jaroslav Rosenberger, Pavol Jozef Safarik University

Brief Summary:
The study will investigate the effects of an intradialytic resistance training on miRNA´s expression and muscle strength in haemodialysis patients.

Condition or disease Intervention/treatment Phase
Chronic Kidney Disease Requiring Chronic Dialysis Behavioral: Intradialytic resistance training Not Applicable

Detailed Description:
Chronic kidney disease (CKD) is accompanied by distortions of immune functions and acceleration of inflammation processes. Regular exercise has shown great potential for improving the health-related parameters of CKD patients. Moreover, muscle strength is considered to be an important predictor of protein- and energy- wasting, inflammation, quality of life and mortality in CKD patients. The behaviour and individual variability of adaptation to regular, controlled, supervised physical activities in CKD patients are not well defined and understood. The understanding of molecular adaptation mechanisms, represented by the epigenetic impact of exercise on renal specific miRNA´s expression, is necessary for future improvements in clinical practice. Monitoring pro- and anti-inflammation genes activity, their transcription factors and expression of miRNA molecules (influencing the signalling pathways of specific genes) will enable us to draft a new transcription and translation model for exercise-induced adaptation in CKD patients. Additionally, our results will indicate the clinical value of selected markers for the diagnostics and prognostics of disease.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 90 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Effect of Intradialytic Resistance Training on Circulatory miRNA Profile and Muscle Strength in Haemodialysis Patients
Actual Study Start Date : January 11, 2018
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dialysis

Arm Intervention/treatment
Experimental: Intradialytic resistance training
During the 12-week intradialytic training plan subjects will be performed 3 to 5 sets of 3 different lower extremities exercises, each set will consist of 12 up to 18 repetitions of a single exercise. Subjects will take 1 to 2 minutes rest between each set. The resistance training will be realized 3 times per week and will be performed during haemodialysis therapy.
Behavioral: Intradialytic resistance training
Progressive resistance training programme performed during haemodialysis, taking into account subject´s medical review summarizing: A. full medical history, B. clinical examination including cardiovascular assessment, C. detailed medication usage history, D. review of recent biochemistry and haematology records and results of lower extremity muscle strength assessments. Construction of intradialytic training programme followed recommendations published by the Exercise & Sports Science Australia (Smart et al., 2013).

No Intervention: Control programme
Control subjects will receive no intervention during the 12-weeks of the experiment. Through the 12-week control period, all participants will be instructed to maintain a standard treatment regimen and to maintain their customary dietary and physical activity patterns.



Primary Outcome Measures :
  1. Change in lower extremity muscle strength [ Time Frame: Before the intervention, 1-5 days after the completion of the 12-week intervention and after 3 months follow up ]
    Change in maximal voluntary force produced during knee extension, leg flexion, extension and hip abduction, adduction will be assessed by dynamometer


Secondary Outcome Measures :
  1. Change in activity of circulatory miRNA molecules involved in TRIM63 and IGF-1 signalling pathways [ Time Frame: Before the intervention and 1-5 days after the completion of 12-week intervention ]
    Blood plasma will be collected for miRNAs analysis. We will analyze the activity of miRNAs involved in TRIM63 and IGF-1 signalling pathways for better definitions of chronic renal insufficiency and muscular adaptation following progressive resistance training. For miRNA analysis, we selected circulatory miRNA´s which were previously connected with regulation of calcium metabolism, calcification processes, protein-energy wasting, muscle mass and functions

  2. Change in renal specific clinical data [ Time Frame: Before the intervention, 1-5 days after the completion of the 12-week intervention and after 3 months follow up ]
    Clinical data will be collected from the medical documentation of patients. The extracted database will contain patient´s nephrological diagnosis profile, data about the presence of other diagnosis and comorbidities, body composition parameters and standard dialysis biochemistry, haematology and dialysis adequacy measures.

  3. Change in score on the Hospital Anxiety and Depression Scale [ Time Frame: Before the intervention and 1-5 days after the completion of 12-week intervention ]
    The Hospital Anxiety and Depression Scale (HADS) will be used to assess states of depression and anxiety in the setting of a hospital medical outpatient clinic. The HADS consists of two subscales, subscale for anxiety and subscale for depression. Both subscales contains seven items and each item is rated on a four-point scale (numeric score range from 0 to 3 points). Maximal score for both subscales is 21, minimal score is 0. Scores of 11 or more on either subscale are considered to be a significant indicator of psychological morbidity. Scores between 8 and 10 represents "borderline" and scores between 0 and 7 represents "normal" indication of anxiety and depression.

  4. Change in score on the Kidney Disease Quality of Life [ Time Frame: Before the intervention and 1-5 days after the completion of 12-week intervention ]
    Kidney Disease Quality of Life (KDQOL™) instrument will be used to assess generic and kidney-disease targeted aspects of quality of life (self-rated health, self-rated change of health status, physical and mental component) of patients on haemodialysis.


Other Outcome Measures:
  1. Satisfaction with Life Scale [ Time Frame: 1-5 days before the intervention ]
    The Satisfaction With Life Scale will be used for measurements of the life satisfaction component of subjective well-being.

  2. Multidimensional Scale of Perceived Social Support [ Time Frame: 1-5 days before the intervention ]
    The Multidimensional Scale of Perceived Social Support will be used to measure how much support a parent feels they get from family, friends and significant others.

  3. Health literacy [ Time Frame: 1-5 days before the intervention ]
    The Health literacy level will be assessed using The Health Literacy Questionnaire and The Brief Health Literacy survey. This questionnaire comprises nine domains to provide a detailed profile of health literacy of populations, groups or patients of interest. The HLQ is divided into two parts which differ in response categories. Part 1 (domains 1-5) has 4 response categories rating the extent of agreement from 1 to 4. Part 2 (domains 6-9) has 5 response categories rating the level of difficulty from cannot do or always difficult (1), to always easy (5). Each domain was scored as the average of the item scores. The score ranges from 1 to 4 or 1 to 5 respectively, a higher score indicating higher level of health literacy.

  4. Karnofsky Performance Status [ Time Frame: 1-5 days before the intervention ]
    The Karnofsky Performance Status (KPS) scale will be used to assess self-sufficiency and functional capacity of patients on haemodialysis. KPS determines functional impairment in the performance of activities of daily living.

  5. Subjective Global Assessment [ Time Frame: 1-5 days before the intervention ]
    The nutritional status of patients will be assessed by Subjective Global Assessment method.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients over 30 years of age, diagnosed with chronic kidney disease, treated with haemodialysis are eligible for our study.

Exclusion Criteria:

  • Lower extremity amputation, severe dementia or retardation, acute intercurrent disease and probability of one year mortality higher than 25 % according to Charlson Comorbidity Index (CCI) are the exclusion criteria for participation in the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03511924


Locations
Layout table for location information
Slovakia
Fresenius Medical Care - Dialysis Services Košice, Slovakia
Košice, Slovakia, 04011
Sponsors and Collaborators
Pavol Jozef Safarik University
Dialysis Services Fresenius Medical Care Slovakia
Private Health Institution Logman - Logman East

Publications:
Layout table for additonal information
Responsible Party: Jaroslav Rosenberger, Jaroslav Resenberger, MD, PhD., Pavol Jozef Safarik University
ClinicalTrials.gov Identifier: NCT03511924     History of Changes
Other Study ID Numbers: PJSU-JR
First Posted: April 30, 2018    Key Record Dates
Last Update Posted: August 26, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Jaroslav Rosenberger, Pavol Jozef Safarik University:
resistance training
circulating miRNA
muscle strength
Additional relevant MeSH terms:
Layout table for MeSH terms
Kidney Diseases
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency